Pluri Chairman Invests $2.5M at 30% Premium in Private Placement
Chairman Alejandro Weinstein has committed a further $2.5 million in a private placement at a 30% premium, acquiring 625,000 common shares and warrants for an additional 625,000 shares. The funding bolsters Pluri’s working capital for its 3D cell expansion platform across regenerative medicine, foodtech and agtech.
1. Private Placement Terms
The Securities Purchase Agreement provides a $2.5 million investment by an entity beneficially owned by Chairman Alejandro Weinstein at a 30% premium to the March 24 market price, delivering 625,000 common shares and warrants exercisable for an additional 625,000 shares at $4.25 per share for 18 months.
2. Chairman Investment Motivation
This follows Weinstein’s initial $2.5 million commitment tied to his board appointment and underscores his confidence in Pluri’s proprietary 3D cell expansion platform, strong intellectual property portfolio and long-term value creation strategy.
3. Use of Proceeds and Strategic Focus
Pluri intends to allocate the gross proceeds to general working capital and corporate purposes, supporting commercialization and scale-up of its cell-based solutions across regenerative medicine, foodtech and agtech verticals.